Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Wize Pharma Inc.

Division of Can-Fite BioPharma Ltd.
www.wizepharma.com

Latest From Wize Pharma Inc.

Deal Watch: Castle Creek Likes Partner Fibrocell Enough To Buy It

Dermatology-focused regenerative medicine firm Fibrocell has been reviewing strategic opportunities for more than a year; April’s FCX-007 license deal with Castle Creek results in buyout.

Deals Business Strategies

Medical Device Deals Update, June-July 2015

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced May-June 2015.

Medical Device

Deals In Depth: May 2015

Sigma-Tau sold Baxter its leukemia drug Oncaspar for $900 million; CVS boosted its retail pharmacy business with Omnicare purchase. There was a strong showing of PIPEs in the $3 billion in biopharma financing.

BioPharmaceutical Medical Device

Deals Shaping The Medical Industry, June 2015

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in May 2015.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
  • Pharmaceuticals
  • Therapeutic Areas
  • Ophthalmic
  • Alias(es)
  • OphthaliX Inc.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Middle East
      • Israel
  • Parent & Subsidiaries
  • Can-Fite BioPharma Ltd.
  • Senior Management
  • Noam Danenberg, CEO
    Or Eisenberg, CFO
  • Contact Info
  • Wize Pharma Inc.
    Phone: 472 260 0536
    24 Hanagar St.
    Hod Hasharon, NV 4527708
    Israel
Advertisement
Advertisement
UsernamePublicRestriction

Register